Photograph Credit score: kate_sept2004 / Getty Photos
SOURCES:
Kimberley Lee, MD, assistant member, division of breast oncology, Moffitt Most cancers Heart.
Rachel Greenup, MD, affiliate professor of surgical procedure (oncology, breast), Yale Faculty of drugs; chief, breast surgical procedure, The Breast Heart at Smilow Most cancers Hospital.
Anne Marie McCarthy, PhD, assistant professor of epidemiology, Perelman Faculty of Drugs, College of Pennsylvania.
Eric Winer, MD, professor of pharmacology; professor of drugs (medical oncology), Yale Faculty of Drugs; director, Yale Most cancers Heart; physician-in-chief, Smilow Most cancers Community.
Frontiers in Molecular Biosciences: “Triple-Adverse Breast Most cancers: A Temporary Evaluate About Epidemiology, Threat Components, Signaling Pathways, Therapy and Function of Synthetic Intelligence.”
American Most cancers Society: “Breast Most cancers Threat Components You Can’t Change,” “Examine: New Genes Linked With Triple-Adverse Breast Most cancers,” “American Most cancers Society Suggestions for the Early Detection of Breast Most cancers.”
Journal of the Nationwide Most cancers Institute: “Triple-Adverse Breast Most cancers Threat Genes Recognized by Multigene Hereditary Most cancers Panel Testing.”
CDC: “Household Well being Historical past and the BRCA1 and BRCA2 genes,” “Household Well being Historical past Threat Classes,” “BRCA Gene Mutations.”
Present Breast Most cancers Reviews: “Disparities in Genetic Testing and Care amongst Black girls with Hereditary Breast Most cancers.”
JAMA Surgical procedure: “Analysis of Triple-Adverse Breast Most cancers Early Detection through Mammography Screening and Outcomes in African American and White American Sufferers.
